Aprameya Engineering Limited is engaged in the business of installation, set up & maintenance of Intensive Care Units (“ICU”), Neonatal Intensive Care Units (“NICU”), Pediatric Intensive Care Units (“PICU”), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as “Healthcare Infrastructure projects”) in the hospitals and medical care centres on turnkey basis along with supply of high value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals and medical practitioners.

Aprameya Engineering IPO, a Book Built issue amounting to ₹29.23 crores, consisting entirely a Fresh Issue of 50.4 lakh Shares. The subscription period for the Aprameya Engineering IPO opens on July 25, 2024, and closes on July 29, 2024. The allotment is expected to be finalized on or about Tuesday, July 30, 2024, and the shares will be listed on the NSE SME with a tentative listing date set on or about Thursday, August 1, 2024.

The Share price band of Aprameya Engineering IPO is set at ₹56 to ₹58 equity per share, with a minimum lot size of 2,000 shares. Retail investors are required to invest a minimum of ₹116,000, while the minimum investment for High-Net-Worth Individuals (HNIs) is 2 lots (4,000 shares), amounting to ₹232,000.

HEM SECURITIES LIMITED is the book-running lead manager, LINK INTIME INDIA PRIVATE LIMITED is the registrar for the Issue. HEM FINLEASE PRIVATE LIMITED is the Market Marker for the Aprameya Engineering IPO.

Aprameya Engineering Limited IPO GMP Today
The Grey Market Premium of Aprameya Engineering Limited IPO is expected in the range of ₹ 0 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Esprit Stones Limited IPO Live Subscription Status Today
As of 07:47 PM on 26 July 2024, the Esprit Stones Limited IPO live subscription status shows that the IPO subscribed 5.50 times on day 2 . Check the Esprit Stones Limited IPO Live Subscription Status Today at NSE.

Aprameya Engineering Limited IPO Allotment Status
Aparmeya Engineering IPO allotment date is 30 July, 2024, Tuesday. Aprameya Engineering IPO Allotment will be out on 30th July 2024 and will be live on Registrar Website from the allotment date. Check Aprameya Engineering Limited IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Aprameya Engineering Limited IPO from the dropdown list of IPOs.
- Enter your application number, PAN, or DP Client ID.
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Aprameya Engineering Limited IPO
Aprameya Engineering Issue Proceeds from the Fresh Issue will be utilized towards the following objects :
1. ₹2,100.00 Lakhs is required to meet incremental working capital requirements (including augmentation on Long Term Working Capital)
2. General corporate purpose

Refer to Aprameya Engineering Limited RHP for more details about the Company.

Read more

About Aprameya Engineering Limited

APRAMEYA ENGINEERING LIMITED and its Group of Companies was founded by two medical engineers, Mr. Saurabh Bhatt and Mr. Chetan Joshi, in 2003 as a healthcare solution provider by partnering with many leading multinational and Indian OEM’s.

By Keeping this generous thought in mind, a venture called “APRAMEYA GROUP” was initiated before Two Decades. The excellent experience and expertise of more than one decade in the delivering the best globally available medical solutions for supreme patient care at reasonable outlay has converted a tiny company into a reputed and triumphant organization.

Their ultimate goal to leverage the most intuitive and innovative products and medical solutions to the least ordinary person. Therefore, they have taken abiding privilege of collaborate with numerous Indian, German, European, American and other Manufacturers across the globe.

They strongly consider business ethics as the only growth strategy to survive in a long run in healthy competitive market and to emerge as THE ENGINEERS FOR HEALTH in the industry.

In today's era, they, Aprameya Engineering Limited working in key area of Turnkey project solution for various operation theater just like Turnkey Project for Modular OT, Turnkey Project for ICU, NICU, CCU and Prefabricated Project. Also Hospital Design, Equipment Procure, supply and Commissioning & installation Planning are other key work area of this main segment for that the service is playing a vital role after sales service equipment.

The intensity of commitment of the company towards service support is reflected by their most competent and easily accessible service hierarchy, which has made them the most trustworthy player in healthcare industry and organization of utmost choice.

They have surpassingly evolved service department to support after sales services and maintenance. Service and maintenance are performed by engineers with higher technical education and certified by manufacturers. Their field team, skilled technicians, are ready to perform installation, maintenance and warranty service for all the equipment delivered by the company.

They started the business of setting up of ICUs and operation theatres in 2020, and have since then completed the installation of around 2000 critical care beds including ICUs, NICUs, PICUs and modular operation theatre across the state of Rajasthan. These healthcare infrastructure projects have been undertaken for different government hospital namely Dr. S N Medical College - Jodhpur, Government Medical College - Kota, RMSCL - Jaipur, RNT Medical College - Udaipur and SMS Medical College – Jaipur. Further, during the Fiscal year 2024, we have undertaken setting up, installing and commissioning of dialysis centres for Rajasthan Services Medical Corporation Limited in over 150 different locations in the state of Rajasthan.

INDIAN HEALTHCARE INDUSTRY
Strong growth in healthcare expenditure over the years
• Healthcare has become one of India's largest sectors, both in terms of revenue and employment. The industry is growing at a tremendous pace owing to its strengthening coverage, service and increasing expenditure by public as well private players. 
• Between 2016–22, the market is expected to record a CAGR of 22.52%. 
• The total industry size is estimated to reach US$ 372 billion by 2022. 
• The e-health market size is estimated to reach US$ 10.6 billion by 2025. 
• In November 2021, the Government of India, the Government of Meghalaya and the World Bank signed a US$ 40 million health project for the state of Meghalaya. This project will improve the quality of health services and strengthen the state’s capacity to handle future health emergencies, including the COVID-19 pandemic.

Per capita healthcare expenditure has risen at a fast pace 
• This is due to rising income, easier access to high-quality healthcare facilities and greater awareness of personal health and hygiene. 
• ▪ Greater penetration of health insurance aided the rise in healthcare spending, a trend likely to intensify in the coming decade. 
• ▪ Economic prosperity is driving the improvement in affordability for generic drugs in the market. 
• ▪ The budgeted spending on the health sector by the federal and state governments was 2.1% of Gross Domestic Production (GDP) in FY23 and 2.2% in FY22, up from 1.6% in FY21. The Government is planning to increase public health spending to 2.5% of the country's GDP by 2025

Healthcare infrastructure has risen at a fast pace 
• India’s medical educational infrastructure has grown rapidly in the last few decades. 
• By FY22, Indian healthcare infrastructure is expected to reach US$ 349.1 billion. 
• As of May 2023, the number medical colleges in India stood at 654. 
• The number of allopathic doctors, with recognised medical qualifications (under the I.M.C Act), registered with state medical councils/national medical council increased to 1.3 million in June 2022, from 0.83 million in 2010. 
• As per information provided to the Lok Sabha by the Minister of Health & Family Welfare, Dr. Bharati Pravin Pawar, the doctor population ratio in the country is 1:834, assuming 80% availability of 12.68 lakh registered allopathic doctors and 5.65 lakh AYUSH doctors. 
• Multinational healthcare company Abbott has committed to converting 75 Primary Health Centers (PHCs) to Health and Wellness Centers (HWCs) in nine Indian States, in collaboration with Americares India Foundation, a nonprofit organisation dedicated to relief and development in the field of health. This will benefit over 2.5 million people from under-resourced communities every year.

APRAMEYA ENGINEERING LIMITED STRENGTHS
1. Rapid growth in the business with focus on setting up of healthcare infrastructure.
2. Track record of execution capabilities of setting up ICUs, NICUs, PICUs as well as Operation Theatre.
3. Firm arrangement with many medical equipment suppliers and manufacturers
4. Wide customer base including many Private and Government Hospital /Medical college
5. Experienced Promoters with technical team having domain knowledge
6. Asset light scalable business model

APRAMEYA ENGINEERING LIMITED STRATEGIES
1. Expanding their geographical footprint
2. Continue to enhance their core strengths and execution capability
3. Intend to expand in-house capabilities in service & maintenance.
4. Strengthen and establish relationships with hospitals and Medical colleges

APRAMEYA ENGINEERING LIMITED RISK FACTORS & CONCERNS
1. Loss of any of their key customers or significant reduction in demand from, their significant customers may materially and adversely affect their business and financial performance.
2. Many of their work orders are awarded primarily through competitive bidding processes
3. They depend significantly on customers and their spending in the healthcare infrastructure industry.
4. They have diversified into the business related to installation, set up & maintenance of ICU, NICU, PICU, Dialysis centres and Operation Theatre in the recent past and are subject to risks associated with new offerings and may not successfully implement their new business models.
5. They derive a significant portion of their revenue from the state of Rajasthan.